Literature DB >> 3136918

Differential expression of a novel gene, WDNM1, in nonmetastatic rat mammary adenocarcinoma cells.

T N Dear1, I A Ramshaw, R F Kefford.   

Abstract

Subtractive hybridization was used to investigate differences in gene expression between a metastatic clone and nonmetastatic clone of the rat mammary adenocarcinoma line DMBA-8 which differ 100-fold in their metastatic behavior. Several differentially expressed highly homologous mRNAs (600 to 900 base pairs) were identified from the nonmetastatic line which are expressed at a level 20-fold higher than in the metastatic clone. Available sequence data show no homology to published gene sequences. There is no difference between the metastatic and nonmetastatic clones regarding DNA restriction fragment sizes or copy number of the gene. Expression of this newly described gene, named WDNM1, may be an important correlate of nonmetastasis in this tumor model.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3136918

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

1.  Dome formation in cell cultures as expression of an early stage of lactogenic differentiation of the mammary gland.

Authors:  I Zucchi; L Bini; D Albani; R Valaperta; S Liberatori; R Raggiaschi; C Montagna; L Susani; O Barbieri; V Pallini; P Vezzoni; R Dulbecco
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-19       Impact factor: 11.205

2.  Tumor progression- and metastasis-associated proteins identified using a model of locally recurrent rat mammary adenocarcinomas.

Authors:  D R Welch; S A McClure; P A Aeed; M J Bahner; L D Adams
Journal:  Clin Exp Metastasis       Date:  1990 Nov-Dec       Impact factor: 5.150

Review 3.  Tumor progression: potential role of unstable genomic changes.

Authors:  R P Hill
Journal:  Cancer Metastasis Rev       Date:  1990-09       Impact factor: 9.264

4.  Cloning and identification of genes differentially expressed in metastatic and non-metastatic rat rhabdomyosarcoma cell lines.

Authors:  L Daigneault; R Beaulieu; M Filion; L Gaboury; A Royal; F Babaï
Journal:  Clin Exp Metastasis       Date:  1995-09       Impact factor: 5.150

5.  Overexpression of metastatic tumor antigen in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma.

Authors:  Hye-Rim Park; Woon Won Jung; Hyun Sook Kim; Patrizia Bacchini; Franco Bertoni; Yong-Koo Park
Journal:  Cancer Res Treat       Date:  2005-12-31       Impact factor: 4.679

6.  Positive selection of candidate tumor-suppressor genes by subtractive hybridization.

Authors:  S W Lee; C Tomasetto; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

7.  Candidate metastasis-associated genes of the rat 13762NF mammary adenocarcinoma.

Authors:  S D Pencil; Y Toh; G L Nicolson
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

8.  eNAP-2, a novel cysteine-rich bactericidal peptide from equine leukocytes.

Authors:  M A Couto; S S Harwig; J S Cullor; J P Hughes; R I Lehrer
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

9.  Wdnm1-like, a new adipokine with a role in MMP-2 activation.

Authors:  Yu Wu; Cynthia M Smas
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-05-20       Impact factor: 4.310

10.  Overexpression of Mos, Ras, Src, and Fos inhibits mouse mammary epithelial cell differentiation.

Authors:  B Jehn; E Costello; A Marti; N Keon; R Deane; F Li; R R Friis; P H Burri; F Martin; R Jaggi
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.